PR Newswire Asia's news > Medical/Pharmaceuticals

 |   Detail   |   Print    Next page > 
     
Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease
2026-05-16T    Education   Health Care/Hospital   Higher Education   Medical/Pharmaceuticals 
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
2026-05-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Malaysia Healthcare Week Myanmar 2026 Opens in Yangon with Leading Hospitals Showcasing Specialised Care for Myanmar Patients
2026-05-15T    Health Care/Hospital   Medical/Pharmaceuticals   Travel   Trade show news 
Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial
2026-05-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026
2026-05-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ozelle Wins German Innovation Award Gold for Advancing the Fourth Generation of Hematology Analysis
2026-05-15T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Herbalgy Trophy & "Goal-Getter Giveaway" - A Triumphant Return
2026-05-15T    Entertainment   Health Care/Hospital   Medical/Pharmaceuticals 
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of 'SNB-101'
2026-05-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NeuroEndocrine Cancer Australia unveils new website and digital lifeline
2026-05-15T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results
2026-05-15T    Health Care/Hospital   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.